Pidilizumab (Anti-PDCD1 / PD-1 / CD279)
Pidilizumab (Anti-PDCD1 / PD-1 / CD279) is a humanized monoclonal antibody targeting human PD-1 (programmed cell death 1; PDCD1). It has immunomodulating and antitumor activities and can be used in treatment of metastatic melanoma. MW :144.48 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A3035 |
Sku # | A3035-1mg*5 |
Pricing | 1mg*5, $1690.00 |